2005 Press releases and earlier years
13 October 2005
Clavis Pharma announces inclusion of first patient in Phase II study with the novel cancer drug ELACYT
Clavis Pharma announces inclusion of first patient in Phase II study with the novel cancer drug ELACYT
7 September 2005
Clavis Pharma announces IND approval for Phase II with the novel cancer drug ELACYT™
Clavis Pharma announces IND approval for Phase II with the novel cancer drug ELACYT™
15 August 2005
Clavis Pharma achieves European Approval of broad platform patent for Lipid Vector Technology
Clavis Pharma achieves European Approval of broad platform patent for Lipid Vector Technology
24 September 2004
Clavis Pharma's anti-cancer drug CP-4055 shows promise of efficacy in successful Phase I clinical study
Clavis Pharma's anti-cancer drug CP-4055 shows promise of efficacy in successful Phase I clinical study
19 February 2003
Clavis Pharma Initiates Phase I/II Clinical Trial with Novel Anticancer Agent for the Treatment of Solid Tumours
Clavis Pharma Initiates Phase I/II Clinical Trial with Novel Anticancer Agent for the Treatment of Solid Tumours